A cellular co-enzyme central to energy production, DNA repair, and the kind of steady mental clarity that age tends to soften — replenished where it's needed.
Nicotinamide adenine dinucleotide — NAD+ — is one of the most fundamental molecules in human biology. It's a co-enzyme present in every cell, central to energy production in the mitochondria, DNA repair, and the activity of sirtuin enzymes that influence cellular aging. Levels decline measurably with age, stress, alcohol use, and chronic illness.
Oral NAD+ precursors like NMN and NR raise levels modestly, but parenteral NAD+ — injection or intranasal — bypasses absorption losses and delivers the molecule itself. Members typically describe the experience not as stimulation but as restoration: steadier energy through the day, fewer afternoon flat-lines, sharper focus, and easier recovery.
Subcutaneous injection is dosed twice weekly and produces a stronger pulse with a longer interval. Intranasal is daily and gives a smoother curve — many members find it the easier rhythm to maintain. Your clinician will recommend the route that fits your goals.
Compounded NAD+ is dispensed only by accredited 503A U.S. pharmacies under your clinician's order, with each batch tested for potency, sterility, pH, and endotoxins.
Every member's curve is a little different. The shape below is the typical clinician-guided arc.
You begin twice-weekly injections (or daily nasal). Many members notice steadier energy within seven to ten days.
Cellular pools approach saturation. Sleep quality, focus, and recovery typically feel more reliable.
Your clinician reviews response and may adjust cadence — some members step down, others hold the loading rhythm.
A simpler weekly or daily rhythm keeps levels stable. Cycling on and off seasonally is also an option.
NAD+ isn't for everyone, and we don't pretend otherwise. Your clinician will confirm fit during your eligibility review.
A brief warm or flushed feeling during or shortly after dosing is the most-reported sensation, especially with faster delivery. It resolves within minutes and tends to fade with adaptation.
Mild redness or warmth at the IM/subQ site is uncommon and self-resolving. Rotate sites and warm the dose to room temperature.
Brief tingle or sniffle with the intranasal route is common in the first week. Saline rinse before dosing helps.
Usually tied to dosing speed. Slower injection or splitting the dose typically resolves it.
Billed monthly. Pause or cancel from your dashboard in one click. Final price is set after clinician review and may vary based on dose and protocol.
Take the twelve-minute eligibility review. A licensed clinician will read your intake, recommend a protocol — or tell you honestly that we're not the right fit. Either way, you'll know within a day.